Newbridge Financial Services Group, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $391 Million
- Q1 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 1,260 shares of RXRX stock, worth $5,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,260
Previous 2,460
48.78%
Holding current value
$5,758
Previous $16,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$159 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$148 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$111 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$79.1 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$67 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $825M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...